Atnaujinkite slapukų nuostatas

El. knyga: Cardio-Nephrology: Confluence of the Heart and Kidney in Clinical Practice

Edited by , Edited by , Edited by
  • Formatas: PDF+DRM
  • Išleidimo metai: 31-Jul-2017
  • Leidėjas: Springer International Publishing AG
  • Kalba: eng
  • ISBN-13: 9783319560427
  • Formatas: PDF+DRM
  • Išleidimo metai: 31-Jul-2017
  • Leidėjas: Springer International Publishing AG
  • Kalba: eng
  • ISBN-13: 9783319560427

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

Extending from the outpatient management of cardiovascular and kidney disease, to hospital-based decision making in patients with cardio-renal disease and complex interfaces such as hemodialysis in patients with ventricular assist device support, this book serves as a single reference point for cardiology and nephrology clinicians and researchers dealing with the significant overlap areas between these two specialties.  Chapters cover the physiology, biomarkers, therapeutic agents and full spectrum of these comorbidities and feature separate sections on cardiovascular and CKD evaluations, stratification of kidney transplant patients, lipid management in CKD, interventional strategies and hypertension.  Leaders in cardiology, nephrology, hypertension and lipidology bring together the latest evidence with their collective clinical experience into this invaluable resource.This textbook is an essential resource for physicians and allied professionals practicing cardiology, nephrology, students and physician trainees, to deepen their understanding of this crucial field.     

 

Recenzijos

It provides an advanced knowledge base for nephrologists caring for their patients with cardiovascular disease. The book is appropriate for practicing nephrologists, or trainees looking for more specialized knowledge. Overall, this book provides an extensive and accessible review of current cardio-nephrology practice, and would serve as an excellent resource for clinicians looking to expand their knowledge on a common intersection of pathology. (Paul Adams, Doody's Book Reviews, February, 2018)

PART I: CARDIOVASCULAR DISEASE SPECTRUM IN CHRONIC KIDNEY DISEASE.-
Chapter 1 Endothelial Dysfunction and Nitric Oxide: Albuminuria as a Central
Marker.
Chapter 2 Vascular and Valvular Calcification in Chronic Kidney
Disease: Pathogenesis and Clinical Outcomes.
Chapter 3 Sudden Cardiac Death
in CKD and ESKD: Risk Factors, Mechanisms, and Therapeutic Strategies.-
Chapter 4 Coronary Artery Disease in CKD: Traditional and Nontraditional Risk
Factors, Diagnosis and Management.
Chapter 5 CKD Associated Cardiomyopathy:
Molecular Mechanisms, Imaging Modalities, Disease Evolution and
Interventions.- PART II: CHRONIC KIDNEY DISEASE AND CAD: TWO SIDES OF THE
SAME COIN.
Chapter 6 CKD as CAD Equivalent: Inflammatory Milieu and Vascular
Oxidative Stress.
Chapter 7 Phosphorus and Mortality: Do we have the
Panacea?.
Chapter 8 Inhibition of the Renin Angiotensin System: How far have
we come?.
Chapter 9 Vitamin D and its Role in CKD and CAD: A Novel
Therapeutic Target.
Chapter 10 Association ofCatalytic (Labile) Iron with
Cardiovascular Morbidity and Mortality.
Chapter 11 Erythropoietin and its
Cardiovascular Effects.- PART III: CARDIO-RENAL SYNDROME.
Chapter 12
Pathophysiology of the Cardio-Renal Syndromes Types 15: Updates from the
Eleventh Consensus Conference of the Acute Dialysis Quality Initiative
(ADQI).
Chapter 13 Hemodynamic Cross Talk in Cardiorenal Syndrome: Era of
Biomarkers.
Chapter 14 Kidney Attack: Is NGAL Set to Take the Stage with
Troponins?.
Chapter 15 Ultrafiltration Therapy in Decompensated Heart
Failure.
Chapter 16 Bioimpedance Vectorial Analyses in Cardio Renal
Syndrome.
Chapter 17 Novel Therapies for Acute Decompensated Heart Failure.-
Chapter 18 Kidney Injury in Patients with Ventricular Assist Devices.-
Chapter 19 Palliation with Dual Burden of Heart and Kidney Failure: An
Underutilized Strategy.- PART IV: CARDIAC EVALUATION OF THE RENAL TRANSPLANT
CANDIDATE.
Chapter 20 Screening Strategies for Coronary Artery Disease (CAD)
in Candidates for Kidney Transplants.
Chapter 21 Cardiac Pre-Operative
Evaluation as an Opportunity to Optimize Risk Factors in Kidney Transplant
Candidates.
Chapter 22 Revascularization in Patients on the Renal Transplant
List: When and What is Appropriate?.
Chapter 23 Pulmonary Hypertension in
the Potential Kidney Transplant Recipient.
Chapter 24 Cardiac Surveillance
whilst Listed for Renal Transplantation.
Chapter 25 Post Kidney Transplant
Modification of Cardiovascular Risk.- Ch. 26 Cardiomyopathy in the Potential
Kidney Transplant Candidate.- PART V: ANTICOAGULATION AND ANTIPLATELET
THERAPY IN CKD.
Chapter 27 Anticoagulation in Patients with Atrial
Fibrillation and Chronic Kidney Disease.
Chapter 28 Anticoagulation-Related
Nephropathy: Tip of the Iceberg.
Chapter 29 Impact of Antiplatelet Therapy
and Platelet Reactivity Testing on Cardiovascular Outcomes in Patients with
Chronic Kidney Disease.- PART VI: INTERVENTIONAL STRATEGIES IN CARDIOVASCULAR
DISEASE IN CKD.
Chapter 30 Revascularization Strategies in Chronic Kidney
Disease: Percutaneous Coronary Intervention vs. Coronary Artery Bypass Graft
Surgery.
Chapter 31 Revascularization Strategies in CKD: Anti-Platelet
Therapy, Stent Type, Timing, and Complications of PCI.
Chapter 32 Peripheral
Arterial Disease in CKD: Disease Burden, Outcomes and Interventional
Strategies.
Chapter 33 Contrast Induced Nephropathy.
Chapter 34 Acute
Kidney Injury after Cardiac Surgery.- PART VII: THE CARDIORENOMETABOLIC
SPECTRUM.
Chapter 35 Dyslipidemias in CKD and ESKD: Outcomes and
Management.
Chapter 36 The Cardiac Impact of Atherosclerotic Renovascular
Disease (ARVD).
Chapter 37 Preeclampsia: A Mirror into Future Cardiovascular
and Renal Health.
Chapter 38 Obstructive Sleep Apnea: A Unifying Link
between Cardiovascular and Renal Disease.- PART VIII: DILEMMAS IN
HYPERTENSION.
Chapter 39 Chronic Kidney Disease and BP Goals.
Chapter 40
Renal Artery Stenosis: Diagnosis and Management.
Chapter 41 Renal
Denervation: Current Opinions and Practice.
Janani Rangaswami, MD

Associate Program Director

Department of Internal Medicine

Einstein Medical Center, Philadelphia

Delaware Valley Nephrology Associates, Philadelphia

Clinical Associate Professor

Sidney Kimmel College of Thomas Jefferson University, Philadelphia.

 

Edgar. V. Lerma, MD

Clinical Professor of Medicine

Section of Nephrology

University of Illinois at Chicago College of Medicine/

Advocate Christ Medical Center





Chicago, IL

 



Claudio Ronco, MD

Professor, Director of the Department of Nephrology and Transplantation

International Renal Research Institute (IRRIV)

San Bortolo Hospital

Vicenza, Italy